Elutia entered into agreement with Vizient to provide access to EluPro

Elutia (ELUT) announced that it has entered into an agreement with Vizient for the benefit of Southern Strategic Sourcing Partners, to provide access to Elutia’s innovative EluPro Antibiotic Eluting BioEnvelope to S3P’s extensive network of 993 acute care facilities, starting immediately. “We are excited to partner with S3P to expand access to EluPro, our innovative solution for preventing post-surgical device complications,” said Dr. Randy Mills, Chief Executive Officer of Elutia. “This marks a pivotal milestone as we secure our second major GPO partnership ahead of EluPro’s full commercial launch later this month. With SP3’s extensive network spanning over a dozen U.S. states, this collaboration significantly accelerates our mission to deliver life-changing technology to more patients, empowering them to heal and thrive without compromise.”